FDA approves Telix Pharmaceuticals’ prostate cancer treatment

By Sarojini P

January 3, 2022

- Advertisement - (adsbygoogle = window.adsbygoogle || []).push({});

Sydney, Australia (CU)_ Illuccix, a prostate cancer imaging tool developed by Telix Pharmaceuticals (TLX), has been authorized by the US Food and Drug Administration. The product is a kit for making an…

Sarojini P https://www.commonwealthunion.com/

Tags
Australia
cancer
commonwealthunion
FDA
News
treatment

Hot this week

- Advertisement - (adsbygoogle = window.adsbygoogle || []).push({});

- Advertisement -

Popular Categories

AsiaHealthcareScience & TechBusiness & TradeEuropeNewsAfrica

ANZ issues an apology to overseas investors

Malaysia demonstrates healthcare supremacy at Expo 2020 Dubai

FDA approves Telix Pharmaceuticals’ prostate cancer treatment

Can Lana Nusseibeh Win the UN’s Top Job When the World’s Most Powerful Nations Cannot Agree?

India’s Student Startup Boom Has a Surprising Twist: Why Are So Few Young Founders Reaching Their First Customer?

A proud moment for Indian fashion: Two Indian-origin models shine at Victoria’s Secret Fashion Show 2026!

A proud moment for Indian cinema: Ramayana’s grand premiere at Los Angeles Academy Museum!

Digital Camouflage: The Shirt That Disguises What Surveillance AI Can’t See

Related Articles

Researchers Identify Circadian Depression Linked to the Body’s Internal Clock

Processed Food Could Affect How Your Brain and Body Work

Your Brain May Begin Learning to Recognise Faces Before Birth, Study Finds

Why Do Chili Peppers Burn? Scientists Find Clues That Could Help Treat Pain

Women with Autoimmune Diseases More Likely to Face Misdiagnosis and Delayed Treatment